The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA case-control studyAstrid van Hylckama Vlieg, Frits R. Rosendaal, Frans M. Helmerhorst et al.|BMJ|2009Cited by 664
Combined oral contraceptives: venous thrombosisBernardine H. Stegeman, Frits R. Rosendaal, Astrid van Hylckama Vlieg et al.|Cochrane Database of Systematic Reviews|2014Cited by 397
Venous thrombosis in the elderly: incidence, risk factors and risk groupsM.J. Engbers, Frits R. Rosendaal, Astrid van Hylckama Vlieg|Journal of Thrombosis and Haemostasis|2010Cited by 366
High levels of factor IX increase the risk of venous thrombosisAstrid van Hylckama Vlieg, Frits R. Rosendaal, I K van der Linden et al.|Blood|2000Cited by 361
Meta-analysis of 65,734 Individuals Identifies TSPAN15 and SLC44A2 as Two Susceptibility Loci for Venous ThromboembolismMarine Germain, Pierre‐Emmanuel Morange, Daniel I. Chasman et al.|The American Journal of Human Genetics|2015Cited by 274